(MDT) Medtronic Launches KYPHON System to Treat Vertebral Compression Fractures

September 22nd, 2009

Medtronic, Inc. (MDT) recently launched the KYPHON Cement Delivery System [CDS] in the U.S. on a full-scale basis. The new product is an addition to the company’s extensive KYPHON Balloon Kyphoplasty product portfolio used for the treatment of vertebral compression fractures (VCFs).

The KYPHON Cement Delivery System enables physicians to maintain a safer and longer distance from the radiation source during the cement delivery phase compared to the company’s traditional delivery system. It decreases the radiation exposure exponentially. The new product launch is a shot in the arm for Medtronic as it will increase sales in the Spinal and Biologics segment and strengthen the company’s leadership position in this market. Spinal is Medtronic’s second-largest revenue generating segment, representing roughly 23% of total revenues.

The company has widely used its balloon kyphoplasty products with an estimated over 700,000 fractures treated globally till date. Medtronic is one of the world’s leading medical technology companies, specializing in implantable and interventional therapy devices and products. The company’s main competitors include St. Jude Medical (STJ) and Boston Scientific Corporation (BSX).

Medtronic’s management has a typical ‘ONE Medtronic’ approach that encompasses the following goals: drive sustainable long-term growth of 9%-11% through innovation; focus on operating margins — increase by 300 to 400 basis points; EPS growth of 11%-14% and return a minimum of 40%-50% of free cash flow to shareholders annually; and align the organization for consistent execution. Medtronic’s first quarter of fiscal 2010 results indicate that the company is well on track in achieving these goals.

Zacks Investment Research
View original at: Zacks.com News Feed

More on this topic (What's this?)
The world according to Steven Wright (Investment Postcards from Cape Town, 6/17/09)
Frigid North and Sunday’s Best (Canadian Personal Finance Blog, 1/14/12)
In Today's Crazy Markets, Here's the One Global Region to Invest in Now (Money Morning, 9/27/11)
Three Peaks Domed House Déjà Vu All Over Again (Wall Street Sector Selector, 1/28/12)
Read more on Medtronic, Kyphon at Wikinvest

Related Posts:

  1. (MDT) Medtronic Recalls Defibrillator ProductMedtronic, Inc. (MDT) is recalling some LifePak CR defibrillators as humidity may cause them to...
  2. (MDT) Medtronic Warned Doctors of Faulty BatteriesMedtronic, Inc. (MDT) has recently warned doctors that approximately 6,300 of the company’s implanted heart...
  3. (MDT) Positive Drug Trial Results for MedtronicMedtronic, Inc. (MDT) announced positive results from its REVERSE trial, which was designed to evaluate...
  4. (MDT) Earnings Preview for MedtronicMedtronic, Inc. (MDT) will report its fiscal first quarter results tomorrow before the market opens....
  5. (MDT) Medtronic Meets Earnings ExpectationsMedtronic, Inc. (MDT) reported results for the first quarter of fiscal 2010. Earnings per share...
  6. (MDT) Medtronic Launches New DeviceMedtronic Inc. (MDT) recently launched a new vertebral body replacement device, T2 SCEPTOR Distractible End...


Search Posts by Tag: | | | | | | Healthcare | Medical Appliances & Equipment

RSS Feeds by Tag: Boston Scientific Corporation | BSX | MDT | Medtronic Inc | St. Jude Medical Inc | STJ | Healthcare | Medical Appliances & Equipment |

Other Posts by: | RSS Feed for this author